ACM
ROIV icon

Anfield Capital Management’s Roivant Sciences ROIV Stock Holding History

Anfield Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.31M Buy
119,451
+500
+0.4% +$12.8K 0.91% 24
2025
Q4 		$2.58M Sell
118,951
-36,693
-24% -$724K 0.81% 26
2025
Q3 		$2.35M Buy
+155,644
New +$1.93M 0.69% 31

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Anfield Capital Management's ROIV Position: Q1 2026 in Review

Anfield Capital Management increased its Roivant Sciences (ROIV) stake by 0.42% in Q1 2026, buying an estimated $12.8K and bringing the position to 119,451 shares worth $3.31M. The position accounts for 0.91% of the portfolio, ranked #24.

Anfield Capital Management first reported a position in ROIV in Q3 2025 and has held it in 3 quarters since. 444 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Anfield Capital Management held 119,451 shares of Roivant Sciences worth $3.31M as of Q1 2026.
  • Anfield Capital Management bought 500 Roivant Sciences shares in Q1 2026, an estimated $12.8K.
  • Roivant Sciences made up 0.91% of Anfield Capital Management's portfolio in Q1 2026, its #24 holding.
  • Anfield Capital Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 3 quarters since.
  • 444 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.